BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 10397789)

  • 1. Addition of positively charged tripeptide to N-terminus of the Fos basic region leucine zipper domain: implications on DNA bending, affinity, and specificity.
    Mahmoudi T; Sarkar B
    Biopolymers; 1999 Sep; 50(3):273-86. PubMed ID: 10397789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The designed protein M(II)-Gly-Lys-His-Fos(138-211) specifically cleaves the AP-1 binding site containing DNA.
    Harford C; Narindrasorasak S; Sarkar B
    Biochemistry; 1996 Apr; 35(14):4271-8. PubMed ID: 8605175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.
    Cohen DR; Curran T
    Oncogene; 1990 Jun; 5(6):929-39. PubMed ID: 2113670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
    Ramirez-Carrozzi VR; Kerppola TK
    J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing fos oncoprotein to a jun-independent DNA binding protein with GCN4 dimerization specificity by swapping "leucine zippers".
    Sellers JW; Struhl K
    Nature; 1989 Sep; 341(6237):74-6. PubMed ID: 2505087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
    Kerppola TK; Curran T
    Oncogene; 1994 Mar; 9(3):675-84. PubMed ID: 8108109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a sensitive peptide-based immunoassay: application to detection of the Jun and Fos oncoproteins.
    Heuer KH; Mackay JP; Podzebenko P; Bains NP; Weiss AS; King GF; Easterbrook-Smith SB
    Biochemistry; 1996 Jul; 35(28):9069-75. PubMed ID: 8703910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. fos-jun Conspiracy: implications for the cell.
    Verma IM; Ransone LJ; Visvader J; Sassone-Corsi P; Lamph WW
    Princess Takamatsu Symp; 1989; 20():119-26. PubMed ID: 2518685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coupling of folding and DNA-binding in the bZIP domains of Jun-Fos heterodimeric transcription factor.
    Seldeen KL; McDonald CB; Deegan BJ; Farooq A
    Arch Biochem Biophys; 2008 May; 473(1):48-60. PubMed ID: 18316037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucine zippers of fos, jun and GCN4 dictate dimerization specificity and thereby control DNA binding.
    Kouzarides T; Ziff E
    Nature; 1989 Aug; 340(6234):568-71. PubMed ID: 2505081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behind the Fos and Jun leucine zipper.
    Kouzarides T; Ziff E
    Cancer Cells; 1989 Nov; 1(3):71-6. PubMed ID: 2518283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncoiling c-Jun coiled coils: inhibitory effects of truncated Fos peptides on Jun dimerization and DNA binding in vitro.
    Yao S; Brickner M; Pares-Matos EI; Chmielewski J
    Biopolymers; 1998; 47(4):277-83. PubMed ID: 10036969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of a high-affinity DNA pool for a bZip protein with an out-of-phase alignment of the basic region relative to the leucine zipper.
    Lee Y; Gurnon DG; Hollenbeck JJ; Oakley MG
    Bioorg Med Chem; 2001 Sep; 9(9):2335-9. PubMed ID: 11553473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
    Hirai S; Yaniv M
    New Biol; 1989 Nov; 1(2):181-91. PubMed ID: 2562220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. fos and jun interaction: the role of the leucine zipper.
    Ransone LJ; Visvader J; Lamph WW; Sassone-Corsi P; Verma IM
    Int J Cancer Suppl; 1989; 4():10-21. PubMed ID: 2509385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes.
    Bannister AJ; Cook A; Kouzarides T
    Oncogene; 1991 Jul; 6(7):1243-50. PubMed ID: 1907361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of DNA bending by Fos-Jun and phased A tracts by multifactorial phasing analysis.
    Kerppola TK
    Biochemistry; 1997 Sep; 36(36):10872-84. PubMed ID: 9283077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat maf-related factors: the specificities of DNA binding and heterodimer formation.
    Matsushima-Hibiya Y; Nishi S; Sakai M
    Biochem Biophys Res Commun; 1998 Apr; 245(2):412-8. PubMed ID: 9571165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Fos protein containing the Jun leucine zipper forms a homodimer which binds to the AP1 binding site.
    Neuberg M; Adamkiewicz J; Hunter JB; Müller R
    Nature; 1989 Sep; 341(6239):243-5. PubMed ID: 2506451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.